bioRxivMicrobiology
Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in Argentina
M. Rivas, M. Pichel, M. Colonna, A. Lopez Casanello, L. Alconcher, J. Galavotti, I. Prinicipi, S. Perez Araujo, F. B. Ramirez, G. Gonzalez, L. Pianciola, M. Mazzeo, A. Suarez, S. Oderiz, L. F. Ghezzi, D. J. Arrigo, J. H. Paladini, M. R. Baroni, S. Perez, A. Tamborini, I. Chinen, E. S. Miliwebsky, F. Goldbaum, L. Munoz, L. Spatz, , E. TEAM
Abstract
In Argentina, the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC-HUS) infection is endemic, and reliable data about prevalence and risk factors are available since 2000. However, information about STEC-associated bloody diarrhea (BD) cases is limited. A prospective study was carried out in seven tertiary-hospitals and 18 Referral Units from different regions, aiming to determine (i) STEC-positive BD cases frequency in 714 children aged 1 to 9 years old; and (ii) rate of progression to HUS. The number and regional distribution of STEC-HUS cases assisted in the same hospitals and period was also assessed. A total of 29 (4.1%) STEC-positive BD cases were confirmed by Shiga Toxin Quik Chek (STQC) and/or mPCR. The highest frequencies were found in the Southern region (Neuquen, 8.7%; Bahia Blanca, 7.9%), in children between 12 and 23 month of age (8.8%), during summertime. Four (13.8%) cases progressed to HUS, three to five days after BD onset. Twenty-seven STEC-HUS children mainly under 5 years old (77.8%) were enrolled, 51.9% were female; 44% were Stx-positive by STQC and all by mPCR. The most common serotypes were O157:H7 and O145:H28 and prevalent genotypes were stx2a-only or associated, both among BD and HUS cases. Considering the endemic behavior of HUS and its impact on public health, it is important to have updated information about the epidemiology of the diarrheal disease for early recognition of infected patients and initiation of supportive treatment. Finally, it also gives the opportunity to respond to outbreak situations effectively and in timely manner.
- organism: E. coli
- assay: clinical cohort / trial
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Temporal dynamics and acquisition of Shiga toxin subtype stx2a within Shiga toxin-producing Escherichia coli in England, 2016 to 2024
Eleanor H. Hayles, Ella V. Rodwell, … Gemma C. Langridge·bioRxiv·Apr 12, 2026
- Recent O-antigen diversification masks highly pathogenic STEC O104:H4
C. Lang, A. Fruth, … A. Flieger·bioRxiv·Sep 15, 2022
- Seasonal prevalence and characterization of Shiga toxin-producing Escherichia coli on pork carcasses at three steps of the harvest process at two commercial processing plants in the US
I. J. Nastasijevic, J. W. Schmidt, … J. M. Bosilevac·bioRxiv·Jul 15, 2020
- Virulence gene profiles and phylogeny of Shiga toxin-positive Escherichia coli strains isolated from FDA regulated foods during 2010-2017
N. Gonzalez-Escalona, J. Kase·bioRxiv·Nov 4, 2018
- The prevalence and genomic context of Shiga toxin 2a genes in E. coli found in cattle
T. Jinnerot, A. T. P. Tomaselli, … C. Sekse·PLOS ONEPeer-reviewed·Aug 12, 2020
- Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: a genomic epidemiology study
G. A. M. Tarr, L. Chui, … T. A. McAllister·bioRxiv·Apr 5, 2024